D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 40 Citations 6,038 79 World Ranking 17012 National Ranking 6990

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • DNA

Robert A. Lazarus mostly deals with Biochemistry, Molecular biology, Binding site, Peptide sequence and Protein structure. As a part of the same scientific study, he usually deals with the Biochemistry, concentrating on Thrombin and frequently concerns with Plasmin and Kallikrein. Robert A. Lazarus interconnects Receptor, Hepatocyte growth factor and Plasma protein binding in the investigation of issues within Molecular biology.

His Binding site research integrates issues from Stereochemistry, Repressor, Hedgehog signaling pathway and Escherichia coli. His biological study spans a wide range of topics, including Platelet aggregation inhibitor, Corynebacterium, Reductase and Glycoprotein. The Serine study combines topics in areas such as Serine protease and Receptor tyrosine kinase.

His most cited work include:

  • Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. (271 citations)
  • Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist (228 citations)
  • Crystal structure of the HGF β‐chain in complex with the Sema domain of the Met receptor (223 citations)

What are the main themes of his work throughout his whole career to date?

Robert A. Lazarus mainly focuses on Biochemistry, Molecular biology, Serine protease, Peptide sequence and Stereochemistry. His Enzyme, Kallikrein, Nucleic acid, Amino acid and Proteases study are his primary interests in Biochemistry. His Proteases research is multidisciplinary, relying on both Allosteric regulation, Matriptase and Serine.

His work in Molecular biology tackles topics such as DNA which are related to areas like Hydrolysis. Robert A. Lazarus works mostly in the field of Peptide sequence, limiting it down to topics relating to Platelet aggregation inhibitor and, in certain cases, Platelet membrane glycoprotein, as a part of the same area of interest. His Stereochemistry study which covers Phenylalanine hydroxylase that intersects with Carbon-13 NMR, Tyrosine hydroxylase and Cofactor.

He most often published in these fields:

  • Biochemistry (48.67%)
  • Molecular biology (18.00%)
  • Serine protease (13.33%)

What were the highlights of his more recent work (between 2010-2020)?

  • Antibody (7.33%)
  • Immunology (6.00%)
  • Biochemistry (48.67%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Antibody, Immunology, Biochemistry, Allosteric regulation and Proteases. His work carried out in the field of Immunology brings together such families of science as Cancer research, Receptor tyrosine kinase and Hepatocyte growth factor. His studies deal with areas such as Onartuzumab, Molecular biology, Inflammatory bowel disease and Binding site as well as Receptor tyrosine kinase.

His Biochemistry research focuses on Nucleic acid, Enzyme, Intron, Signal peptide and Hydrolase. In his research on the topic of Allosteric regulation, Cell type and Receptor is strongly related with Tryptase. Robert A. Lazarus has researched Proteases in several fields, including Serine protease, Active site, Serine and Cell biology.

Between 2010 and 2020, his most popular works were:

  • A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo (215 citations)
  • Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent (162 citations)
  • Proteolytic Activation of Pro-Macrophage-Stimulating Protein by Hepsin (47 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • DNA

Robert A. Lazarus spends much of his time researching Allosteric regulation, Immunology, Antibody, Enzyme and Proteases. His Antibody research includes elements of Plasma protein binding, Cathepsin, Asthma, Biomarker and Peptide. His Enzyme study combines topics from a wide range of disciplines, such as DNA and Magnesium ion.

His work deals with themes such as Serine and Cell biology, which intersect with Proteases. His study with Active site involves better knowledge in Biochemistry. The study of Biochemistry is intertwined with the study of Magnesium in a number of ways.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors.

Mark S. Dennis;William J. Henzel;Robert M. Pitti;Michael T. Lipari.
Proceedings of the National Academy of Sciences of the United States of America (1990)

408 Citations

Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist

Marc Adler;Robert A. Lazarus;Mark S. Dennis;Gerhard Wagner.
Science (1991)

341 Citations

Peptide exosite inhibitors of factor VIIa as anticoagulants

Mark S. Dennis;Charles Eigenbrot;Nicholas J. Skelton;Mark H. Ultsch.
Nature (2000)

279 Citations

Crystal structure of the HGF β‐chain in complex with the Sema domain of the Met receptor

Jennifer Stamos;Robert A Lazarus;Xiaoyi Yao;Daniel Kirchhofer.
The EMBO Journal (2004)

276 Citations

Production of 2-Keto-L-Gulonate, an Intermediate in L-Ascorbate Synthesis, by a Genetically Modified Erwinia herbicola

Stephen Anderson;Cara Berman Marks;Robert Lazarus;Jeffrey Miller.
Science (1985)

261 Citations

A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo

Jasvinder K. Atwal;Yongmei Chen;Cecilia Chiu;Deborah L. Mortensen.
Science Translational Medicine (2011)

237 Citations

Interactions between Hedgehog proteins and their binding partners come into view

Philip A. Beachy;Sarah G. Hymowitz;Robert A. Lazarus;Daniel J. Leahy.
Genes & Development (2010)

200 Citations

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

Mark Merchant;Xiaolei Ma;Henry R. Maun;Zhong Zheng.
Proceedings of the National Academy of Sciences of the United States of America (2013)

190 Citations

Structure of the RGD protein decorsin: conserved motif and distinct function in leech proteins that affect blood clotting.

Andrzej M. Krezel;Gerhard Wagner;Jana Seymour-Ulmer;Robert A. Lazarus.
Science (1994)

180 Citations

Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.

Daniel Kirchhofer;Mark Peek;Wei Li;Jennifer Stamos.
Journal of Biological Chemistry (2003)

163 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert A. Lazarus

Daniel Kirchhofer

Daniel Kirchhofer

Genentech

Publications: 44

R. Manjunatha Kini

R. Manjunatha Kini

National University of Singapore

Publications: 34

Charles S. Craik

Charles S. Craik

University of California, San Francisco

Publications: 24

Ermanno Gherardi

Ermanno Gherardi

University of Pavia

Publications: 22

Juan J. Calvete

Juan J. Calvete

Spanish National Research Council

Publications: 21

Mark S. Dennis

Mark S. Dennis

Genentech

Publications: 18

Robert F. Kelley

Robert F. Kelley

Genentech

Publications: 16

Kunio Matsumoto

Kunio Matsumoto

Kanazawa University

Publications: 15

Charles Eigenbrot

Charles Eigenbrot

Genentech

Publications: 15

Francis S. Markland

Francis S. Markland

University of Southern California

Publications: 15

Ravi Salgia

Ravi Salgia

City Of Hope National Medical Center

Publications: 15

Henry B. Lowman

Henry B. Lowman

Genentech

Publications: 14

Seymour Kaufman

Seymour Kaufman

National Institutes of Health

Publications: 14

Stephen J. Benkovic

Stephen J. Benkovic

Pennsylvania State University

Publications: 13

Enrico Di Cera

Enrico Di Cera

Saint Louis University

Publications: 13

Stefan Niewiarowski

Stefan Niewiarowski

Temple University

Publications: 13

Trending Scientists

Ji-Rong Wen

Ji-Rong Wen

Renmin University of China

Stefan Hollands

Stefan Hollands

Leipzig University

Makarand M. Ghangrekar

Makarand M. Ghangrekar

Indian Institute of Technology Kharagpur

J. L. Duda

J. L. Duda

Pennsylvania State University

Philippe Marcus

Philippe Marcus

PSL University

Sigfrid Svensson

Sigfrid Svensson

Lund University

Marie-Claude Fournie-Zaluski

Marie-Claude Fournie-Zaluski

Inserm : Institut national de la santé et de la recherche médicale

Lyndal Kearney

Lyndal Kearney

Institute of Cancer Research

Tai-Soon Yong

Tai-Soon Yong

Yonsei University

Moses J. Bockarie

Moses J. Bockarie

European & Developing Countries Clinical Trials Partnership

Miguel A. Aon

Miguel A. Aon

National Institutes of Health

Neville E. Sanjana

Neville E. Sanjana

New York University

Vincent P. Clark

Vincent P. Clark

University of New Mexico

Bart O. Roep

Bart O. Roep

Leiden University Medical Center

Antonio Alcami

Antonio Alcami

Spanish National Research Council

Joellen M. Schildkraut

Joellen M. Schildkraut

Emory University

Something went wrong. Please try again later.